Anaplastic Large Cell Lymphoma, ALK-Negative Active Not Recruiting Phase 1 / 2 Trials for Cefotaxime (DB00493)

Also known as: Anaplastic Large Cell Lymphoma, ALK-negative

IndicationStatusPhase
DBCOND0061449 (Anaplastic Large Cell Lymphoma, ALK-Negative)Active Not Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02561273Combination Chemotherapy and Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Peripheral T-cell Non-Hodgkin's LymphomaTreatment